Shiny K. Kajal/LinkedIn
Feb 5, 2026, 17:35
Shiny K. Kajal: ELISA vs CLIA vs NAT – Comparison of Screening Test for TTis
Shiny K. Kajal, Senior Resident at Adesh University, shared a post on LinkedIn:
“ELISA vs CLIA vs NAT
Understanding the strengths of different screening assays is essential for ensuring blood safety. From conventional serological methods to advanced molecular testing, each technique plays a vital role in detecting transfusion-transmitted infections and reducing the window period.”

Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice